How are States Prioritizing Who Will Get the COVID-19 Vaccine First? December 16, 2020 News Release The first Americans were vaccinated today as COVID-19 vaccines are being distributed across the country. A new KFF review of states’ releases and statements about their vaccination priorities finds that most states are following the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices recommendations for the…
Real Progress Is Possible On Vaccine Hesitancy December 15, 2020 Perspective Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
KFF Launches New COVID-19 Vaccine Monitor to Track the Public’s Confidence in the Vaccine and Experiences for the Duration of the Pandemic December 15, 2020 News Release Republicans and Black Americans are More Likely to Be Hesitant but Even Among These Groups Reasons Vary KFF has launched a new COVID-19 Vaccine Monitor to dive deeply into the public’s views about the vaccine and experiences getting it for as long as the pandemic lasts. First results released today…
KFF COVID-19 Vaccine Monitor: December 2020 December 15, 2020 Report This initial survey for the KFF COVID-19 Vaccine Monitor tracks the public’s attitudes and experiences with COVID-19 vaccinations, with a focus on sub-groups of Americans. It explores confidence in vaccines, assesses trust in messengers, and highlights key challenges for vaccination efforts.
How are States Prioritizing Who Will Get the COVID-19 Vaccine First? December 14, 2020 Blog This post reviews the latest information on state priorities for their initial COVID-19 vaccine allocations to assess which populations will get the vaccine first.
Who Didn’t Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines December 14, 2020 Issue Brief As the U.S. prepares for nationwide distribution of vaccines to combat COVID-19, some are asking whether people who get the first of two doses will return to complete the series. This analysis draws on Medicare Part D prescription drug claims data for the herpes zoster vaccine Shingrix, which also requires two doses, to shed light on this potential challenge of the leading COVID-19 vaccine candidates.
This Week in Coronavirus: December 4 to December 10 December 11, 2020 Blog During the 47th week since the first coronavirus case appeared in the United States, the U.S. surpassed 15.6 million total cases as an independent Food and Drug Administration panel of outside advisers supported emergency use authorization for the Pfizer COVID-19 vaccine.
Web Briefing: Racism and Discrimination in Health Care – Experiences Today and Actions to Address Going Forward December 11, 2020 Event Approaching the end of 2020, two of the most pressing concerns facing the country are the long-standing issue of racial discrimination and the ongoing coronavirus pandemic. The issues have merged with the pandemic taking a disproportionate health and economic toll on people of color. As vaccines become available, prioritizing racial…
New National and State Estimates for Recommended COVID-19 Vaccination Priority Population December 10, 2020 News Release This month the Centers for Disease Control and Prevention (CDC) adopted a recommendation that health care workers and long-term care residents should be the first to receive the COVID-19 vaccine once it is authorized or approved by the FDA. A new KFF analysis estimates there are 15.5 million people working…
Estimates of the Initial Priority Population for COVID-19 Vaccination by State December 10, 2020 Issue Brief This analysis provides new national and state-level estimates of the number of health care workers and long-term care residents who are expected to be part of the group first in line to receive the COVID-19 vaccine to gain insight into how this initial priority population varies across states.